Literature DB >> 33879610

Distinct signaling by insulin and IGF-1 receptors and their extra- and intracellular domains.

Hirofumi Nagao1, Weikang Cai1,2, Nicolai J Wewer Albrechtsen3,4,5, Martin Steger3, Thiago M Batista1, Hui Pan6, Jonathan M Dreyfuss6, Matthias Mann3,4, C Ronald Kahn7.   

Abstract

Insulin and insulin-like growth factor 1 (IGF-1) receptors share many downstream signaling pathways but have unique biological effects. To define the molecular signals contributing to these distinct activities, we performed global phosphoproteomics on cells expressing either insulin receptor (IR), IGF-1 receptor (IGF1R), or chimeric IR-IGF1R receptors. We show that IR preferentially stimulates phosphorylations associated with mammalian target of rapamycin complex 1 (mTORC1) and Akt pathways, whereas IGF1R preferentially stimulates phosphorylations on proteins associated with the Ras homolog family of guanosine triphosphate hydrolases (Rho GTPases), and cell cycle progression. There were also major differences in the phosphoproteome between cells expressing IR versus IGF1R in the unstimulated state, including phosphorylation of proteins involved in membrane trafficking, chromatin remodeling, and cell cycle. In cells expressing chimeric IR-IGF1R receptors, these differences in signaling could be mapped to contributions of both the extra- and intracellular domains of these receptors. Thus, despite their high homology, IR and IGF1R preferentially regulate distinct networks of phosphorylation in both the basal and stimulated states, allowing for the unique effects of these hormones on organismal function.

Entities:  

Keywords:  IGF-1 signaling; cellular signaling; insulin signaling; kinases; protein phosphorylation

Mesh:

Substances:

Year:  2021        PMID: 33879610      PMCID: PMC8092608          DOI: 10.1073/pnas.2019474118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

Review 1.  Molecular basis of insulin action.

Authors:  M Combettes-Souverain; T Issad
Journal:  Diabetes Metab       Date:  1998-12       Impact factor: 6.041

Review 2.  Molecular mechanisms of kinesin-14 motors in spindle assembly and chromosome segregation.

Authors:  Zhen-Yu She; Wan-Xi Yang
Journal:  J Cell Sci       Date:  2017-07-01       Impact factor: 5.285

Review 3.  Genetic evaluation of short stature.

Authors:  Andrew Dauber; Ron G Rosenfeld; Joel N Hirschhorn
Journal:  J Clin Endocrinol Metab       Date:  2014-06-10       Impact factor: 5.958

4.  Early neonatal death in mice homozygous for a null allele of the insulin receptor gene.

Authors:  D Accili; J Drago; E J Lee; M D Johnson; M H Cool; P Salvatore; L D Asico; P A José; S I Taylor; H Westphal
Journal:  Nat Genet       Date:  1996-01       Impact factor: 38.330

Review 5.  Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease.

Authors:  Antonino Belfiore; Francesco Frasca; Giuseppe Pandini; Laura Sciacca; Riccardo Vigneri
Journal:  Endocr Rev       Date:  2009-09-14       Impact factor: 19.871

6.  Differential signalling potential of insulin- and IGF-1-receptor cytoplasmic domains.

Authors:  R Lammers; A Gray; J Schlessinger; A Ullrich
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

Review 7.  Human conditions of insulin-like growth factor-I (IGF-I) deficiency.

Authors:  Juan E Puche; Inma Castilla-Cortázar
Journal:  J Transl Med       Date:  2012-11-14       Impact factor: 5.531

8.  Vimentin is a novel AKT1 target mediating motility and invasion.

Authors:  Q-S Zhu; K Rosenblatt; K-L Huang; G Lahat; R Brobey; S Bolshakov; T Nguyen; Z Ding; R Belousov; K Bill; X Luo; A Lazar; A Dicker; G B Mills; M-C Hung; D Lev
Journal:  Oncogene       Date:  2010-09-20       Impact factor: 9.867

9.  FoxK1 and FoxK2 in insulin regulation of cellular and mitochondrial metabolism.

Authors:  Masaji Sakaguchi; Weikang Cai; Chih-Hao Wang; Carly T Cederquist; Marcos Damasio; Erica P Homan; Thiago Batista; Alfred K Ramirez; Manoj K Gupta; Martin Steger; Nicolai J Wewer Albrechtsen; Shailendra Kumar Singh; Eiichi Araki; Matthias Mann; Sven Enerbäck; C Ronald Kahn
Journal:  Nat Commun       Date:  2019-04-05       Impact factor: 14.919

Review 10.  Regulation of G2/M Transition by Inhibition of WEE1 and PKMYT1 Kinases.

Authors:  Matthias Schmidt; Alexander Rohe; Charlott Platzer; Abdulkarim Najjar; Frank Erdmann; Wolfgang Sippl
Journal:  Molecules       Date:  2017-11-23       Impact factor: 4.411

View more
  6 in total

Review 1.  The insulin receptor family in the heart: new light on old insights.

Authors:  Angela Clerk; Peter H Sugden
Journal:  Biosci Rep       Date:  2022-07-29       Impact factor: 3.976

2.  CircVAPA promotes small cell lung cancer progression by modulating the miR-377-3p and miR-494-3p/IGF1R/AKT axis.

Authors:  Jinghan Hua; Xiaolin Wang; Liying Ma; Jingxin Li; Guozhen Cao; Shaobo Zhang; Wenchu Lin
Journal:  Mol Cancer       Date:  2022-06-06       Impact factor: 41.444

3.  Endothelial Insulin Receptors Promote VEGF-A Signaling via ERK1/2 and Sprouting Angiogenesis.

Authors:  Andrew M N Walker; Nele Warmke; Ben Mercer; Nicole T Watt; Romana Mughal; Jessica Smith; Stacey Galloway; Natalie J Haywood; Taha Soomro; Kathryn J Griffin; Stephen B Wheatcroft; Nadira Y Yuldasheva; David J Beech; Peter Carmeliet; Mark T Kearney; Richard M Cubbon
Journal:  Endocrinology       Date:  2021-08-01       Impact factor: 4.736

Review 4.  Insulin and cancer: a tangled web.

Authors:  Brooks P Leitner; Stephan Siebel; Ngozi D Akingbesote; Xinyi Zhang; Rachel J Perry
Journal:  Biochem J       Date:  2022-03-18       Impact factor: 3.766

5.  Insulin at 100 years - is rebalancing its action key to fighting obesity-related disease?

Authors:  Gemma V Brierley; Robert K Semple
Journal:  Dis Model Mech       Date:  2021-11-29       Impact factor: 5.758

Review 6.  The role of insulin and incretin-based drugs in biliary tract cancer: epidemiological and experimental evidence.

Authors:  Hua Sun; Xiaohui Qi
Journal:  Discov Oncol       Date:  2022-08-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.